Latest News & Features
Americas
Shire Viropharma has filed a complaint against CSL Behring, a developer of rare disease therapies, for patent infringement. 19 April 2017
Americas
The University of California, Berkeley and the University of Vienna have appealed against the Patent Trial and Appeal Board's decision in the dispute over CRISPR technology. 18 April 2017
Asia
Takeda will sell a number of its off-patent drugs, used for treatment of diabetes, hypertension and peptic ulcers, to Teva Takeda Yakuhin for ¥28.5 billion. 17 April 2017
Americas
The US International Trade Commission has launched an investigation into intravascular administration sets, based on a complaint filed by medical device companies Curlin Medicals, Moog and Zevex. 14 April 2017
Americas
Brazil’s President Michel Temer has revealed measures aimed at improving the IP system in the country. 13 April 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling of the Patent Trial and Appeal Board that a patent belonging to Novartis and Mitsubishi Pharma is obvious. 13 April 2017
Big Pharma
The UK government has revealed plans to provide £29 million ($36 million) of funding to the Roslin Institute, part of the University of Edinburgh. 12 April 2017
Americas
The 2017 “Drugs to Watch” report predicts that eight new drugs will enter the market this year and each achieve $1 billion in annual sales by 2021. 12 April 2017
Americas
Shire Viropharma has filed a motion to dismiss a complaint by the Federal Trade Commission, following competition allegations made against the pharmaceutical company. 11 April 2017
Americas
Novartis and Roxane Laboratories have entered into a settlement agreement following a patent dispute between the parties over a cancer treatment. 11 April 2017